Blood damage related to cardiopulmonary bypass: In vivo and in vitro comparison of two different centrifugal pumps

ASAIO Journal

Volumn 50, Issue 5, 2004, Pages 473-478

  Paparella, Domenico ^a   Galeone, Antonella ^a   Venneri, Maria Teresa ^b   Coviello, Maria ^b   Visicchio, Giuseppe ^a   Cappabianca, Giangiuseppe ^a   Maselli, Giorgia ^a   Marraudino, Nicola ^a   Quaranta, Michele ^b   Schinosa, Luigi De Luca Tupputi ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CARDIOLOGY; CENTRIFUGAL PUMPS; COAGULATION; PULMONARY DISEASES; SURGERY;

BIO-PUMP; CARDIOPULMONARY BYPASS (CPB); COAGULATION SYSTEMS; HEMOLYSIS;

CARDIOVASCULAR SYSTEM;

HEMOGLOBIN; PADGEM PROTEIN; PROTHROMBIN; THROMBOCYTE FACTOR;

ADULT; AGED; ARTICLE; BLOOD; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CIRCULATION TIME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE MARKER; FEMALE; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; MALE; MEDICAL INSTRUMENTATION; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

AGED; BLOOD; BLOOD COAGULATION; CARDIOPULMONARY BYPASS; FEMALE; HEART-LUNG MACHINE; HEMOGLOBINS; HEMOLYSIS; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; P-SELECTIN; PEPTIDE FRAGMENTS; PLATELET FACTOR 4; PROTHROMBIN;

EID: 4544346104     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000136514.53139.D0     Document Type: Article

References (20)

1. Paparella D, Yau TM, Young E: Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21: 232-244, 2002.
2. Nishinaka T, Nishida H, Endo M, Miyagishima M, Ohtsuka G, Koyanagi H: Less blood damage in the impeller centrifugal pump: A comparative study with the roller pump in open heart surgery. Artif Organs 20: 707-710, 1996.
3. Morgan IS, Codispoti M, Sanger K, Mankad PS: Superiority of centrifugal pump over roller pump in paediatric cardiac surgery: prospective randomised trial. Eur J Cardiothorac Surg 13: 526-532, 1998.
4. Ashraf SS, Tian Y, Cowan D, et al: Proinflammatory cytokine release during pediatric Cardiopulmonary bypass: influence of centrifugal and roller pumps. J Cardiothorac Vasc Anesth 11: 718-722, 1997.
5. Baufreton C, Intrator L, Jansen PG, et al: Inflammatory response to Cardiopulmonary bypass using roller or centrifugal pumps. Ann Thorac Surg 67: 972-977, 1999.
6. Roth-Isigkeit A, Borstel TV, Seyfarth M, Schmucker P: Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution. Clin Exp Immunol 118: 242-246, 1999.
7. Wright G: Hemolysis during cardiopulmonary bypass: Update. Perfusion 16: 345-351, 2001.
8. Ohtsubo S, Tayama E, Short D, Noon CP, Nosè Y: Clinical comparative study of cardiopulmonary bypass with Nikkiso and BioMedicus centrifugal pumps. Artif Organs 20: 715-720, 1996.
9. Araki K, Taenaka Y, Masuzawa T, et al: Hemolysis and heat generation in six different types of centrifugal blood pumps. Artif Organs 19: 928-932, 1995.
10. Naito K, Suenaga E, Cao Z, et al: Comparative hemolysis study of clinically available centrifugal pumps. Artif Organs 20: 560-563, 1996.
11. Steines D, Westphal D, Gobel C, Reul H, Rau G: Platelet function and hemolysis in centrifugal pumps: in vitro investigations. Int J Artif Organs 22: 559-565, 1999.
12. Brister SJ, Ofosu FA, Buchanan MR: Thrombin generation during cardiac surgery: Is heparin the ideal anticoagulant? Thromb Haemost 70: 259-262, 1993.
13. 1+2. Thromb Haemost 70: 253-258, 1993.
14. Parolari A, Colli S, Mussoni L: Coagulation and fibrinolytic markers in a two month follow-up of coronary bypass surgery. J Thorac Cardiovasc Surg 125: 336-343, 2003.
15. Zilla P, Fasol R, Groscurth P, Klepetko W, Reichenspurner H, Wolner E: Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. J Thorac Cardiovasc Surg 97: 379-388, 1989.
16. Cella G, Vittadello O, Gallucci V, Girolami A: The release of β thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery. Eur J Clin Invest 11: 165-169, 1981.
17. Khuri SF, Valeri CR, Loscalzo J: Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 60: 1008-1014, 1995.
18. Valeri CR, Khabbaz K, Khuri SF: Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg 104: 108-116, 1992.
19. Kristiansen G, Schluns K, Yongwei Y, Denkert C, Dietel M, Petersen I: CD24 is an independent prognostic marker of survival in non small cell lung cancer patients. Br J Cancer 88: 231-236, 2003.
20. Macey MG, McCarthy DA, Trivedi UH, Venn GE, Chambers DJ, Brown KA: Neutrophil adhesion molecule expression during cardiopulmonary bypass: a comparative study of roller and centrifugal pumps. Perfusion 12: 293-301, 1997.